Neurofeedback and Nomophobia in Young Adults
Effectiveness of a Neurofeedback Intervention on Symptoms of Anxiety and Psychological Distress Associated With Smartphone Use in Young Adults
1 other identifier
interventional
40
1 country
1
Brief Summary
Introduction: Given the growing increase in addiction to social networks and smartphone use in young people and its implications for health, it is necessary to investigate effective interventions for the appropriate use of these technologies and coping with possible signs of addiction. Objective: To evaluate the effect of an intervention based on neurofeedback techniques on anxiety and other disorders associated with problematic use of mobile phones and the internet in young adults. Methodology: Randomised controlled clinical trial with two parallel groups: an intervention group (IG) and a control group (CG). The study population will be young adults aged 18-30 years. A sample size of 40 participants has been estimated, 20 in each group to detect a difference of 3.9 points or more on the DASS-21 anxiety questionnaire. All participants will receive an educational workshop on the responsible use of new technologies and the promotion of healthy lifestyles. The IG, in addition to this educational workshop, will receive 25 neurofeedback sessions during 12 weeks, 2-3 sessions/week with the MUSE neurofeedback device. A baseline and 3-month post-intervention assessment will be conducted for both groups to study change variables related to smartphone addiction (Smartphone Addiction Scale-Short Version (SAS-SV)), nomophobia (Nomophobia Questionnaire (NMP-Q)), depression, anxiety and stress (Depression, Anxiety and Stress Scale 21-item (DASS-21)) and sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
January 3, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedSeptember 29, 2025
September 1, 2025
9 months
December 18, 2023
September 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Anxiety
Anxiety evaluated through Depression, Anxiety and Stress Scale 21-item (DASS-21). Minimum 0 - maximum 63
Baseline, 3-months
Secondary Outcomes (2)
Nomophobia
Baseline, 3-months
Sleep Quality
Baseline, 3-months
Study Arms (2)
Neurofeedback
EXPERIMENTAL3 weekly 30-minute neurofeedback sessions per week for 12 weeks
Control
ACTIVE COMPARATORHealth education, a 25-minute session, on mobile phone addiction and promotion of healthy lifestyles
Interventions
Conducting neurofeedback sessions guided by a researcher
Eligibility Criteria
You may qualify if:
- Have one or more mobile devices such as smartphones.
- Have a compatible mobile device to install and use the Muse: EEG Meditation \& Sleep application.
- Be fully functional.
- Willingness to voluntarily participate in the study and sign the informed consent form.
You may not qualify if:
- History of severe psychiatric disorders (such as schizoaffective disorders, bipolar disorder, major depressive episode with symptoms or other non-organic psychotic disorders) requiring psychiatric treatment in the 6 months prior to study entry.
- History of brain injury or other problems contraindicating the use of neurofeedback.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Salamanca
Salamanca, Salamanca, 37007, Spain
Related Publications (2)
Fernandez-Crespo M, Rihuete-Galve MI, Sanchez-Aguadero N, Sanchez-Sanchez N, Gonzalez-Sanchez J, Garcia-Yu IA, Lee HC, Recio-Rodriguez JI. Efficacy of neurofeedback-assisted mindfulness for anxiety and nomophobia in Spanish young adults: a randomized controlled trial. Front Public Health. 2025 Dec 2;13:1712564. doi: 10.3389/fpubh.2025.1712564. eCollection 2025.
PMID: 41409706DERIVEDFernandez-Crespo M, Recio-Rodriguez JI, Lee HC, Alonso-Dominguez R, Montejo AL, Hernandez-Gonzalez L, Iglesias Sierra V, Rihuete-Galve MI. Study protocol of a proposed Neurofeedback-Assisted Mindfulness Training Program on symptoms of anxiety and psychological distress associated with smartphone use in young adults: a randomized controlled trial. Front Public Health. 2024 Sep 4;12:1410932. doi: 10.3389/fpubh.2024.1410932. eCollection 2024.
PMID: 39296829DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
José Ignacio Recio Rodriguez, PhD
University of Salamanca
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 18, 2023
First Posted
January 3, 2024
Study Start
April 1, 2024
Primary Completion
December 31, 2024
Study Completion
February 28, 2025
Last Updated
September 29, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share